APP and Alzheimer disease: The present findings also may explain the reduction of IGF-I effects on cortical activity in an animal model of Alzheimer’s disease (APP/PS1 mouse) in which a reduction of ACh neurotransmission is a hallmark of this disease (Trueba-Sáiz et al., 2013).